Abscopal Effect for Metastatic Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Patients with small cell lung cancer that had metastatic lesions after been treated with
definitive surgery or chemoradiotherapy are being asked to participate in this study.
1. To observe immunity-mediated tumor response outside the radiation field (abscopal
effect) after chemoradiotherapy of a metastatic site in metastatic small cell lung
cancer patients.
2. To induce the efficacy (effectiveness) of a new combination of therapy,
chemoradiotherapy and thymalfasin for heavily pretreated, metastatic small cell lung
cancer patients;
3. To explore the role of PET/CT scanning to assess tumor response/abscopal effect.
This study will help find out what abscopal effects (good or bad) the combination of
radiotherapy and thymalfasin has on metastatic small cell lung cancer.